Raul Rodriguez Ramirez, MD - Medicare Internal Medicine in Searcy, AR

Raul Rodriguez Ramirez, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Searcy, Arkansas. He graduated from medical school in 1970 and has 54 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Primary Care 360 and his current practice location is 606 W Arch Ave, Ste. A, Searcy, Arkansas. You can reach out to his office (for appointments etc.) via phone at (501) 279-0211.

Raul Rodriguez Ramirez is licensed to practice in Arkansas (license number R4544) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1720081789.

Contact Information

Raul Rodriguez Ramirez, MD
606 W Arch Ave, Ste. A,
Searcy, AR 72143-5206
(501) 279-0211
(501) 279-0213



Physician's Profile

Full NameRaul Rodriguez Ramirez
GenderMale
SpecialityInternal Medicine
Experience54 Years
Location606 W Arch Ave, Searcy, Arkansas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Raul Rodriguez Ramirez graduated from medical school in 1970
  NPI Data:
  • NPI Number: 1720081789
  • Provider Enumeration Date: 05/24/2005
  • Last Update Date: 10/04/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 9638126568
  • Enrollment ID: I20060717000359

Medical Identifiers

Medical identifiers for Raul Rodriguez Ramirez such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1720081789NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease R4544 (Arkansas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Gentiva HospiceLittle rock, ARHospice

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Primary Care 36041830508423

News Archive

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Raul Rodriguez Ramirez allows following entities to bill medicare on his behalf.
Entity NameSt Vincent Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134176480
PECOS PAC ID: 5698758803
Enrollment ID: O20040622000224

News Archive

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Read more Medical News

› Verified 1 days ago

Entity NamePrimary Care 360
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124678586
PECOS PAC ID: 4183050842
Enrollment ID: O20200129001002

News Archive

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Read more Medical News

› Verified 1 days ago

Entity NameAmerican Hope And Health Clinic Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538781208
PECOS PAC ID: 0547674293
Enrollment ID: O20210121000277

News Archive

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Raul Rodriguez Ramirez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Raul Rodriguez Ramirez, MD
606 W Arch Ave, Ste A,
Searcy, AR 72143-5206

Ph: (501) 279-0211
Raul Rodriguez Ramirez, MD
606 W Arch Ave, Ste. A,
Searcy, AR 72143-5206

Ph: (501) 279-0211

News Archive

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Read more News

› Verified 1 days ago


Internal Medicine Doctors in Searcy, AR

Stephen R. Toothaker, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 415 Rodgers Dr Ste A, Searcy, AR 72143
Phone: 501-278-3100    
Dr. Robert R Camferdam, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 403 S Poplar St Ste D, Searcy, AR 72143
Phone: 501-279-7077    Fax: 501-279-3970
Mitzi Ann Washington, MD
Pulmonary Disease
Medicare: May Accept Medicare Assignments
Practice Location: 400 S Main St, Suite 200, Searcy, AR 72143
Phone: 501-279-0502    Fax: 501-279-0506
John C Henderson, MD
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 2900 Hawkins Dr, Searcy, AR 72143
Phone: 501-278-2808    Fax: 501-278-3001
David Mark Evans, M. D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 711 Santa Fe Dr, Searcy, AR 72143
Phone: 501-279-9393    
Ahmad Radi Abdelhadi Tarawneh, M.D
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2900 Hawkins Dr, Searcy, AR 72143
Phone: 501-278-2800    
Katherine J Durham, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 711 Santa Fe Dr, Searcy, AR 72143
Phone: 501-279-9393    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.